Camden National Bank’s Celgene Corp CELG Stock Holding History

Camden National Bank’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,520	Closed	-$250K	–	146
2019 Q3	$250K	Sell	2,520 -25	-1%	-$2.38K	0.05%	105
2019 Q2	$235K	Sell	2,545 -685	-21%	-$65K	0.05%	105
2019 Q1	$304K	Sell	3,230 -742	-19%	-$64.9K	0.07%	88
2018 Q4	$254K	Buy	3,972 +492	+14%	+$36.3K	0.07%	89
2018 Q3	$311K	Sell	3,480 -353	-9%	-$31.2K	0.08%	85
2018 Q2	$304K	Sell	3,833 -55	-1%	-$4.57K	0.08%	89
2018 Q1	$347K	Buy	3,888 +553	+17%	+$53.1K	0.1%	67
2017 Q4	$348K	Buy	3,335 +300	+10%	+$33.9K	0.1%	64
2017 Q3	$443K	Buy	+3,035	New	+$413K	0.13%	54

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Camden National Bank's CELG Position: Q4 2019 in Review

Camden National Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,520 shares — an estimated $250K sold.

Camden National Bank first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $443K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Camden National Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Camden National Bank sold 2,520 Celgene Corp shares in Q4 2019, an estimated $250K.
Camden National Bank first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
Camden National Bank's Celgene Corp position peaked at $443K in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Camden National Bank's 13F filing for Q4 2019, filed 11 Feb 2020.